In the News:FDA Report on Long-Term Benefits of
Bisphosphonates
On May 10, 2012 the latest FDA
report on using bisphosphonates to treat osteoporosis was published in the New
England Journal of Medicine. To read a summary of their findings and learn what
this means for adults who have OI, please click the link below.
A multidisciplinary panel of researchers and clinicians with expertise in osteogenesis imperfecta met in Chicago, Illinois, April 17-20 for the 12th annual OI Foundation Scientific Meeting. Click the link below to read the full article about this meeting.
A clinical trial of a drug that is
expected to increase bone formation is currently recruiting adult participants.
This trial is sponsored by the pharmaceutical company Novartis. For details
about the study and a description of who is eligible, please click the link below.
